NF-κB modulation and ionizing radiation:: mechanisms and future directions for cancer treatment

被引:157
作者
Magné, N
Toillon, RA
Bottero, V
Didelot, C
Van Houtte, P
Gérard, JP
Peyron, JF
机构
[1] Inst Jules Bordet, Dept Radiotherapy, B-1000 Brussels, Belgium
[2] Inst Jules Bordet, Lab Cancerol Mammaire, B-1000 Brussels, Belgium
[3] INSERM, U526, Fac Med Pasteur, F-06107 Nice 02, France
[4] Univ Libre Bruxelles, Mol Virol Lab, B-1070 Brussels, Belgium
[5] Ctr Antoine Lacassagne, Dept Radiotherapy, F-06189 Nice 2, France
关键词
NF-kappa B; radiotherapy; chemotherapy; cell survival; apoptosis;
D O I
10.1016/j.canlet.2005.01.022
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
NF-kappa B transcription factor regulates important cellular processes ranging from establishment of the immune and inflammatory responses to regulation of cell proliferation or apoptosis, through the induction of a large array of target genes. NF-kappa B is now considered as an important actor in the tumorigenic process mainly because it exerts strong anti-apoptotic functions in cancer cells. NF-kappa B is triggered by chimio- and radio-therapeutic strategies that are intended to eliminate cancerous cells through induction of apoptosis. Numerous studies have demonstrated that inhibition of NF-kappa B by different means increased sensitivity of cancer cells to the apoptotic action of diverses effectors such as TNF alpha or chemo- or radiotherapies. From these studies as emerged the concept that NF-kappa B blockade Could be associated to conventional therapies in order to increase their efficiency. This review focuses on the current knowledge on NF-kappa B regulation and discusses the therapeutic potential of targeting NF-kappa B in cancer in particular during radiotherapy. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:158 / 168
页数:11
相关论文
共 107 条
[81]  
2-R
[82]  
Ravi R, 1998, CANCER RES, V58, P882
[83]  
Ravi R, 1998, CANCER RES, V58, P4531
[84]   CD40 and B chronic lymphocytic leukemia cell response to fludarabine:: The influence of NF-κB/Rel transcription factors on chemotherapy-induced apoptosis [J].
Romano, MF ;
Lamberti, A ;
Turco, MC ;
Venuta, S .
LEUKEMIA & LYMPHOMA, 2000, 36 (3-4) :255-262
[85]   ATM: A mediator of multiple responses to genotoxic stress [J].
Rotman, G ;
Shiloh, Y .
ONCOGENE, 1999, 18 (45) :6135-6144
[86]  
Russell JS, 2002, CANCER RES, V62, P2318
[87]   Radiation-induced activation of nuclear factor-κB involves selective degradation of plasma membrane-associated IκBa [J].
Russell, JS ;
Tofilon, PJ .
MOLECULAR BIOLOGY OF THE CELL, 2002, 13 (10) :3431-3440
[88]   Enhancement of radiosensitivity by proteasome inhibition:: Implications for a role of NF-κB [J].
Russo, SM ;
Tepper, JE ;
Baldwin, AS ;
Liu, R ;
Adams, J ;
Elliott, P ;
Cusack, JC .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 50 (01) :183-193
[89]   Role of NF-κB in p53-mediated programmed cell death [J].
Ryan, KM ;
Ernst, MK ;
Rice, NR ;
Vousden, KH .
NATURE, 2000, 404 (6780) :892-897
[90]   Nuclear localization of IκBα is mediated by the second ankyrin repeat:: the IκBα ankyrin repeats define a novel class of cis-acting nuclear import sequences [J].
Sachdev, S ;
Hoffmann, A ;
Hannink, M .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (05) :2524-2534